Peng Qin - Net Worth and Insider Trading

Peng Qin Net Worth

The estimated net worth of Peng Qin is at least $348,936 dollars as of 2024-12-13. Peng Qin is the senior management of Kangmei Pharmaceutical Co Ltd and owns about 130,200 shares of Kangmei Pharmaceutical Co Ltd (SHSE:600518) stock worth over $348,936. Details can be seen in Peng Qin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peng Qin has not made any transactions after 2015-07-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Peng Qin

To

Peng Qin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peng Qin owns 1 companies in total, including Kangmei Pharmaceutical Co Ltd (SHSE:600518) .

Click here to see the complete history of Peng Qin’s form 4 insider trades.

Insider Ownership Summary of Peng Qin

Ticker Comapny Transaction Date Type of Owner
SHSE:600518 Kangmei Pharmaceutical Co Ltd 2015-07-21 senior management

Peng Qin Latest Holdings Summary

Peng Qin currently owns a total of 1 stock. Peng Qin owns 130,200 shares of Kangmei Pharmaceutical Co Ltd (SHSE:600518) as of July 21, 2015, with a value of $348,936.

Latest Holdings of Peng Qin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:600518 Kangmei Pharmaceutical Co Ltd 2015-07-21 130,200 2.68 348,936

Holding Weightings of Peng Qin


Peng Qin Form 4 Trading Tracker

According to the SEC Form 4 filings, Peng Qin has made a total of 0 transactions in Kangmei Pharmaceutical Co Ltd (SHSE:600518) over the past 5 years. The most-recent trade in Kangmei Pharmaceutical Co Ltd is the acquisition of 30,000 shares on July 21, 2015, which cost Peng Qin around $570,600.

Insider Trading History of Peng Qin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peng Qin Trading Performance

GuruFocus tracks the stock performance after each of Peng Qin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peng Qin is 7.67%. GuruFocus also compares Peng Qin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peng Qin within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peng Qin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peng Qin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
4 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.5 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.79 LIMIT LIMIT LIMIT LIMIT LIMIT

Peng Qin Ownership Network

Ownership Network List of Peng Qin

No Data

Ownership Network Relation of Peng Qin

Insider Network Chart

Peng Qin Owned Company Details

What does Kangmei Pharmaceutical Co Ltd do?

Who are the key executives at Kangmei Pharmaceutical Co Ltd?

Peng Qin is the senior management of Kangmei Pharmaceutical Co Ltd. Other key executives at Kangmei Pharmaceutical Co Ltd include senior management Li Jian Hua , senior management Wang Min , and senior management Lin Guo Xiong .

Kangmei Pharmaceutical Co Ltd (SHSE:600518) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kangmei Pharmaceutical Co Ltd (SHSE:600518) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kangmei Pharmaceutical Co Ltd (SHSE:600518) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kangmei Pharmaceutical Co Ltd (SHSE:600518)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kangmei Pharmaceutical Co Ltd Insider Transactions

No Available Data

Peng Qin Mailing Address

Above is the net worth, insider trading, and ownership report for Peng Qin. Currently GuruFocus does not have mailing address information for Peng Qin.

Discussions on Peng Qin

No discussions yet.